chrX-131081703-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_144967.4(ARHGAP36):c.38C>T(p.Ala13Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000024 in 1,208,691 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 12 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_144967.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ARHGAP36 | NM_144967.4 | c.38C>T | p.Ala13Val | missense_variant | 2/12 | ENST00000276211.10 | |
ARHGAP36 | NM_001282607.2 | c.59-57C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ARHGAP36 | ENST00000276211.10 | c.38C>T | p.Ala13Val | missense_variant | 2/12 | 2 | NM_144967.4 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000271 AC: 3AN: 110621Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 32819
GnomAD3 exomes AF: 0.0000109 AC: 2AN: 183355Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67795
GnomAD4 exome AF: 0.0000237 AC: 26AN: 1098070Hom.: 0 Cov.: 34 AF XY: 0.0000330 AC XY: 12AN XY: 363426
GnomAD4 genome AF: 0.0000271 AC: 3AN: 110621Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 32819
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 22, 2022 | The c.38C>T (p.A13V) alteration is located in exon 2 (coding exon 1) of the ARHGAP36 gene. This alteration results from a C to T substitution at nucleotide position 38, causing the alanine (A) at amino acid position 13 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at